Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
There is an upward development for Twist Bioscience Corp compared to yesterday, with an increase of €1.98 (2.500%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Twist Bioscience Corp.
As a result the target price of 105 € shows a positive potential of 32.14% compared to the current price of 79.46 € for Twist Bioscience Corp.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | 2.500% | 0.126% | -11.809% | 170.180% | 185.314% | 258.574% | -23.449% |
| Pacira Pharmaceuticals | 2.630% | 3.540% | 5.405% | 25.134% | 8.333% | -28.221% | -52.439% |
| Supernus Pharmaceuticals | -2.960% | -4.369% | -2.956% | 35.862% | -8.372% | 42.754% | 79.091% |
| Collegium Pharmaceutical Inc | -0.640% | 0.645% | -1.266% | 18.182% | -24.638% | 57.576% | 51.456% |
Comments
Twist Bioscience (TWST) had its price target raised by Canaccord Genuity Group Inc. from $90.00 to $120.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its "buy" rating reaffirmed by Guggenheim.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Show more
Ratings data for TWST provided by MarketBeat